GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: MDRXD
Buy $19

ALLSCRIPTS HEALTHC (NASDAQ: MDRX) reiterated to Buy with price target $19 by Argus

Friday,  Jan 22, 2016  2:25 PM ET by Kristen Bailey

Argus reiterated ALLSCRIPTS HEALTHC (NASDAQ: MDRX) to Buy with price
target $19. Argus rated ALLSCRIPTS HEALTHC (NASDAQ: MDRX) to Buy with price target $17 on 08/24/2015, when the price was $12.92.

Allscripts-Misys Healthcare Solutions, Inc. (Allscripts), formerly Allscripts Healthcare Solutions, Inc., is a provider of clinical software, services, information and connectivity solutions used by the physicians and other health care providers. The Company?s businesses provide solutions that inform physicians with just right, just in time information, connect physicians to each other and to the entire community of care, and transforming healthcare. Allscripts provide various clinical software applications, including Electronic Health Records (EHR), practice management, revenue cycled management, clearinghouse services, electronic prescribing, Emergency Department Information System (EDIS), hospital care management and discharge management solutions, document imaging solutions, and a range of solutions for home care and other post-acute facilities. The Company operates in two business segments: clinical solutions and health solutions.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy